Literature DB >> 844617

Effects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes.

G G Nahas, A Morishima, B Desoize.   

Abstract

The lymphocyte response to phytohemagglutinin (PHA) as measured by [13H]thymidine incorporation is equally inhibited by 10(-5) to 10(-4) M concentrations of delta8, and delta9-tetrahydrocannabinol (THC), their 11-hydroxymetabolites, cannabidiol, cannabinol, cannabichromene, cannabicyclol. A similar inhibiting effect is produced by olivetol, which has the structure of the C ring common to all of these cannabinoids and their metabolites that accumulate in tissues. THC inhibits intracellular and intramolecular incorporation of thymidine, uridine, and leucine. This inhibition can be observed within 15 min after addition of THC to the culture medium. The cytotoxicity of THC is a function of the concentration of serum in the culture medium. The higher the concentration of serum, the more the cells are protected against the toxicity of THC. The cytotoxicity of THC is reversible by washing, after the cells have been incubated for 24 hr with the drug. Lymphocytes incubated with THC or olivetol present a significantly larger number of hypodiploid cells and a significant increase in segregational errors of chromosomes. The inhibitory effect of THC on macromolecular synthesis might be mediated by an alteration of the plasma membrane by the drug.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 844617

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  19 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  Interaction of delta-9-tetrahydrocannabinol with rat B103 neuroblastoma cells.

Authors:  G A Cabral; P J McNerney; E M Mishkin
Journal:  Arch Toxicol       Date:  1987-08       Impact factor: 5.153

3.  Chronic Δ-9-tetrahydrocannabinol administration increases lymphocyte CXCR4 expression in rhesus macaques.

Authors:  Nicole J LeCapitaine; Ping Zhang; Peter Winsauer; Edith Walker; Curtis Vande Stouwe; Constance Porretta; Patricia E Molina
Journal:  J Neuroimmune Pharmacol       Date:  2011-04-12       Impact factor: 4.147

4.  Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.

Authors:  Ewa Kozela; Nirit Lev; Nathali Kaushansky; Raya Eilam; Neta Rimmerman; Rivka Levy; Avraham Ben-Nun; Ana Juknat; Zvi Vogel
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

5.  Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction.

Authors:  Rebecca Hartzell Robinson; Joseph J Meissler; Jessica M Breslow-Deckman; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-04       Impact factor: 4.147

6.  Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters.

Authors:  Michelle Sexton; Eiron Cudaback; Rehab A Abdullah; John Finnell; Laurie K Mischley; Mary Rozga; Aron H Lichtman; Nephi Stella
Journal:  Inflammopharmacology       Date:  2014-08-19       Impact factor: 4.473

7.  A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10.

Authors:  Rebecca H Robinson; Joseph J Meissler; Xiaoxuan Fan; Daohai Yu; Martin W Adler; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-16       Impact factor: 4.147

8.  Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection.

Authors:  C A Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

9.  Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001-2015.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  BMC Pediatr       Date:  2022-01-19       Impact factor: 2.125

10.  Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.